Bone cells known as osteoblasts were recently shown to have a role in controlling the biochemical reactions that generate energy via secretion of the molecule osteocalcin. A team of researchers, led by Stavroula Kousteni, at Columbia University, New York, has now determined that the protein FoxO1 regulates this function of osteoblasts in mice.
Specifically, FoxO1 increases expression of osteocalcin and decreases expression of Esp, a gene that makes a protein responsible for decreasing the bioactivity of osteocalcin.
This is a new role for FoxO1, which is also involved in regulating glucose levels via effects on cells in the pancreas and liver.
The research is reported in the Journal of Clinical Investigation.
The above post is reprinted from materials provided by Journal of Clinical Investigation. Note: Materials may be edited for content and length.
- Marie-Therese Rached, Aruna Kode, Barbara C. Silva, Dae Young Jung, Susan Gray, Helena Ong, Ji-Hye Paik, Ronald A. Depinho, Jason K. Kim, Gerard Karsenty and Stavroula Kousteni. FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. Journal of Clinical Investigation, 2009; DOI: 10.1172/JCI39901
Cite This Page:
Journal of Clinical Investigation. "Bone control of glucose levels." ScienceDaily. ScienceDaily, 26 December 2009. <www.sciencedaily.com/releases/2009/12/091214220241.htm>.
Journal of Clinical Investigation. (2009, December 26). Bone control of glucose levels. ScienceDaily. Retrieved July 29, 2015 from www.sciencedaily.com/releases/2009/12/091214220241.htm
Journal of Clinical Investigation. "Bone control of glucose levels." ScienceDaily. www.sciencedaily.com/releases/2009/12/091214220241.htm (accessed July 29, 2015).